Webcast CME

Series Activities

Series Menu

Biologic Therapies VIII: The Intersection of Rheumatology and Allied Specialties

Primer of Inflammatory Eye Disease for Rheumatologists 

Print this Content

Release date: November 11, 2019
Expiration date: November 11, 2021

Estimated Time of Completion: 30 minutes

Description

In the Biologic Therapies VIII: The Intersection of Rheumatology and Allied Specialties online series, an international, multi-disciplinary faculty of experts focuses on interdisciplinary rheumatology by exploring the interface of rheumatology with disciplines such as infectious disease, gastroenterology, neurology, oncology, dermatology, pulmonology, ophthalmology, and wellness.

Primer of Inflammatory Eye Disease for Rheumatologists webcast highlights the rheumatology-ophthalmology interface: rheumatic diseases with ocular manifestations.

Learning Objectives

  1. Provides an overview of the rheumatology-ophthalmology interface: rheumatic diseases with ocular manifestations
  2. Review of cases addressing red eye in a patient with rheumatoid arthritis, blurry vision in a patient with lupus, and double vision and proptosis.

Target Audience

The online series is designed for rheumatologists, dermatologists, gastroenterologists, infectious disease physicians, pulmonologists, neurologists, oncologists, ophthalmologists, internal medicine physicians, and allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in complex multiorgan autoimmune and autoinflammatory diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Directors

Leonard H. Calabrese, DO
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

James Rosenbaum, MD
Professor of Ophthalmology, Medicine, and Cell Biology
Head, Division of Arthritis and Rheumatic Diseases
Edward E. Rosenbaum Professor of Inflammation Research
Oregon Health & Science University
Richard Chenoweth Chair of Ophthalmology
Legacy Devers Eye Institute
Portland, OR

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias. 

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:

Leonard H. Calabrese, DO Abbvie Pharmaceuticals, BMS, Genentech/Roche, Janssen, Novartis Consulting
Teaching and Speaking
Crescendo Teaching and Speaking
GSK, Horizon Pharma, Pfizer, Regeneron, Sanofi Aventis, UCB Consulting

M. Elaine Husni, MD Abbvie Pharmaceuticals, Amgen, Genzyme/Sanofi, Janssen, Lilly Consulting
Membership on advisory committee or review panels
Novartis Pharmaceuticals Consulting
Membership on advisory committee or review panels
Teaching and Speaking
Pfizer, Inc. Membership on advisory committee or review panels
WebMD Consulting
Teaching and Speaking

James Rosenbaum, MD Abbvie Pharmaceuticals, Gilead Sciences, Inc, Janssen, Novartis Pharmaceuticals, Roche, UCB Consulting

 

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:

AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Lilly USA, LLC

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Live activity from:

AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb
Crescendo Bioscience, Inc.
Genentech
Janssen Scientific Affairs, LLC
Lilly USA, LLC
Mallinckrodt Pharmaceuticals
Novartis Pharmaceuticals Corporation

 


This CME activity was produced by the Cleveland Clinic Center for Continuing Education
and Cleveland Clinic's RJ Fasenmyer Center for Clinical Immunology.